Results 181 to 190 of about 6,982,631 (374)
The development of brain white matter microstructure
C. Lebel, S. Deoni
semanticscholar +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Pericyte degeneration causes white matter dysfunction in the mouse central nervous system
Axel Montagne +19 more
semanticscholar +1 more source
ABSTRACT Pathogenic variants in KIF1C cause Spastic Paraplegia 58 (SPG58), typically presenting with cerebellar ataxia and spastic paraparesis. We report two unrelated patients with spastic paraparesis, cerebellar ataxia, and tremor. Whole‐exome sequence analysis identified novel homozygous variants in the motor domain of KIF1C (NM_006612.6): c.921G>A (
Akihiko Mitsutake +12 more
wiley +1 more source
Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment
R. Mito +9 more
semanticscholar +1 more source
White Matter Integrity in the Brains of Professional Soccer Players Without a Symptomatic Concussion [PDF]
Inga K. Koerte +4 more
openalex +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
White matter injury in the preterm infant: pathology and mechanisms
S. Back
semanticscholar +1 more source

